Fluid and Imaging Biomarkers in Huntington’s Disease
Growing interest in earlier and mechanism-targeted interventions for Huntington’s disease (HD) has brought focus on biomarkers capable of informing trial design and regulatory pathways. This review discusses recent advances in fluid and neuroimaging biomarkers since the introduction of the HD-Integrated Staging System...